AKT1 and cholangiocarcinoma: Taken together, these data indicate that miR-455-5p play a critical role in controlling CCA growth and mediating the anti-tumor effects of galangin, at least in part, through targeting PPP1R12A and modulating MAPK and PI3K/AKT pathway.